GENOMIC HEALTH INC's ticker is GHDX and the CUSIP is 37244C101. A total of 126 filers reported holding GENOMIC HEALTH INC in Q1 2017. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $5,367,000 | +13.0% | 156,919 | +6.1% | 0.41% | +2.2% |
| Q3 2017 | $4,748,000 | +3.8% | 147,947 | +5.3% | 0.40% | -2.7% |
| Q2 2017 | $4,573,000 | +12.4% | 140,481 | +8.7% | 0.42% | +5.9% |
| Q1 2017 | $4,070,000 | +12.5% | 129,245 | +5.0% | 0.39% | +1.6% |
| Q4 2016 | $3,619,000 | +4.9% | 123,139 | +3.2% | 0.39% | +6.0% |
| Q3 2016 | $3,451,000 | +8.3% | 119,327 | -3.0% | 0.36% | +4.3% |
| Q2 2016 | $3,186,000 | +10.5% | 123,018 | +5.7% | 0.35% | +2.9% |
| Q1 2016 | $2,883,000 | -22.9% | 116,396 | +9.6% | 0.34% | -23.6% |
| Q4 2015 | $3,738,000 | +113.2% | 106,180 | +28.1% | 0.44% | +94.7% |
| Q3 2015 | $1,753,000 | -56.1% | 82,858 | -42.4% | 0.23% | -64.4% |
| Q2 2015 | $3,995,000 | -25.0% | 143,757 | -17.5% | 0.64% | -42.1% |
| Q1 2015 | $5,325,000 | +129.0% | 174,289 | +139.6% | 1.10% | -18.9% |
| Q4 2014 | $2,325,000 | – | 72,732 | – | 1.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,150,000 | $68,736,000 | 4.57% |
| Baker Brothers Advisors | 13,656,318 | $436,592,000 | 4.46% |
| NORTH TIDE CAPITAL, LLC | 1,500,000 | $47,955,000 | 3.22% |
| Motley Fool Wealth Management, LLC | 72,732 | $2,325,000 | 1.36% |
| Tributary Capital Management, LLC | 150,896 | $4,824,000 | 0.82% |
| Champlain Investment Partners, LLC | 1,217,175 | $38,913,000 | 0.62% |
| Motley Fool Asset Management LLC | 71,935 | $2,300,000 | 0.43% |
| IRONBRIDGE CAPITAL MANAGEMENT LP | 440,410 | $14,080,000 | 0.39% |
| CATAPULT CAPITAL MANAGEMENT LLC | 35,000 | $1,119,000 | 0.28% |
| Spark Investment Management LLC | 51,100 | $1,633,000 | 0.27% |